Mode
Text Size
Log in / Sign up
N/A N=11 Randomized Triple-blind Basic Science

Effect of Milk Oligosaccharides and Bifidobacteria on the Intestinal Microflora of Children With Autism

Autism

Enrolled (actual)
11
Serious AEs
0.0%
Results posted
Aug 2019
Primary outcome: Primary: Stool Microbiota Composition Change During Prebiotic Only Treatment — 2; 3; 1; 0 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Synbiotic (Dietary_supplement); Prebiotic (Dietary_supplement)
Age
Pediatric · 2+ yrs
Sex
All
Sponsor
University of California, Davis
Primary completion
Nov 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Stool Microbiota Composition Change During Prebiotic Only Treatment
2; 3; 1; 0; 1; 0
PRIMARY
Stool Microbiota Composition Change During Synbiotic Treatment
4; 2; 0; 1; 0; 1
SECONDARY
Serum Immune Profile Change During Prebiotic Only Treatment
-0.8; -7.9

Summary

The purpose of this study is to determine the tolerability of dietary supplements and if these supplements can promote a healthy bacterial environment in the intestines of children with autism spectrum disorders and gastrointestinal complaints.

Eligibility Criteria

Inclusion Criteria

  • Autism
  • Diarrhea and/or constipation

Exclusion Criteria

  • Milk protein or other documented food allergy
  • Lactose intolerance
  • Compromised Immunity
  • GI conditions (inflammatory bowel disease, celiac disease, short gut, etc.)
  • Systemic steroid, antifungal, or antibiotic use within a month of starting the study
  • Failure to thrive
  • Medically prescribed diets or supplements (including probiotic use within the past month).
  • Vegetarian or dairy restricted diet
  • Other medical conditions (seizures, genetic disorders, liver/pancreatic disease, cystic fibrosis, etc.)
  • Medications that interfere or alter intestinal motility or microbiota composition.
  • Full scale intelligence quotient (IQ) <40
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02086110). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search